Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_assertion type Assertion NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_head.
- NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_assertion description "[CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_provenance.
- NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_assertion evidence source_evidence_literature NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_provenance.
- NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_assertion SIO_000772 18086299 NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_provenance.
- NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_assertion wasDerivedFrom befree-2016 NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_provenance.
- NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_assertion wasGeneratedBy ECO_0000203 NP645691.RAa7G2x-mcVMtrg6Tw66MvxShGyUdkKxG6jLB1yYU9570130_provenance.